INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-71 Cr | ₹-67 Cr | ₹-69 Cr | ₹-37 Cr | ₹-39 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INDEGENE ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-71 Cr |
Mar2023 | ₹-67 Cr |
Mar2022 | ₹-69 Cr |
Mar2021 | ₹-37 Cr |
Mar2020 | ₹-39 Cr |
How is Deferred Tax Assets / Liabilities of INDEGENE Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-71 Cr | Negative | |
Mar2023 | ₹-67 Cr | Negative | |
Mar2022 | ₹-69 Cr | Negative | |
Mar2021 | ₹-37 Cr | Negative | |
Mar2020 | ₹-39 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,789.2 Cr | 4.3% | 9.8% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,123.0 Cr | 0.2% | 1% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,844.0 Cr | 6.8% | 1.6% | 53.3% | Stock Analytics | |
CIPLA | ₹120,860.0 Cr | 4.4% | 2.9% | 4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,020.0 Cr | -0.7% | 4% | 25.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,755.1 Cr | 4.6% | 4.9% | -6.2% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | 4.3% |
9.8% |
|
SENSEX | 5.3% |
4% |
3.2% |
You may also like the below Video Courses